Key result
Intrarenal angiotensin II is hypothesized to play a key role in the development and progression of chronic allograft nephropathy, serving as a theoretical focal point for various factors.
Intrarenal angiotensin II is proposed as a key antigen-independent factor linking various mechanisms in the development and progression of chronic allograft nephropathy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for intrarenal angiotensin II blockade in chronic allograft nephropathy; prospective trials needed before clinical consideration.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Becker et al. (2002) conducted a review in Chronic allograft nephropathy. Angiotensin II (AII) was evaluated. Intrarenal angiotensin II is hypothesized to play a key role in the development and progression of chronic allograft nephropathy, serving as a theoretical focal point for various factors.
Synapse has enriched 10 related papers. Consider them for comparative context: